Michael Yang – Head & Chair Professor of the Biomedical Sciences Department, City University of Hong Kong
17.09.2018
Related Interviews
Oncology / EGFR Pioneer Tony Mok Talks Asian Clinical Trial Trends
One of Asia’s most pre-eminent oncologists, Professor Tony Mok is perhaps best known for discovering the EGFR mutation gene and subsequently developing a targeted therapy that is more precise and…
Derek Chang – Head, Novartis Hong Kong
Novartis, one of the world’s largest biopharma companies, has secured approval and market access for two of its most advanced cell and gene treatments in Hong Kong. The firm’s territory…
Albert Wong – CEO, Hong Kong Science and Technology Parks Corporation
Albert Wong of the Hong Kong Science and Technology Parks Corporation (HKSTP) outlines how Hong Kong has developed as an innovation hub, building on its established areas of finance and…
APAC / The Scientist & Entrepreneur Combining Forces to Change Cancer
Insighta, formed this year as a 50/50 joint venture between genomics-focused outfit Prenetics and one of the city’s most feted scientific sons, Professor Dennis Lo, is aiming to change the…
Hong Kong / Doubling Down on Clinical Research
Almost a decade on from the establishment of a Phase I clinical trial centre in Hong Kong, the city continues to pursue a stronger positioning within the global clinical research…
China / Market Leader AstraZeneca Looking to Replicate Mainland China Innovative Offer in Hong Kong
Ongoing geopolitical tensions between China and the West have led the G7 group of countries to warn of the threat of “economic coercion” from China and the US to scrutinise…
